Prelude Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-20,600
| Closed | -$118K | – | 1673 |
|
|
2022
Q1 | $118K | Buy |
+20,600
| New | +$118K | ﹤0.01% | 1091 |
|
|
2020
Q3 | – | Sell |
-20,146
| Closed | -$296K | – | 1576 |
|
|
2020
Q2 | $296K | Buy |
+20,146
| New | +$296K | 0.02% | 412 |
|
|
2020
Q1 | – | Sell |
-294
| Closed | -$7K | – | 1202 |
|
|
2019
Q4 | $7K | Buy |
+294
| New | +$7K | ﹤0.01% | 1266 |
|
|
2019
Q3 | – | Sell |
-121
| Closed | -$2K | – | 1358 |
|
|
2019
Q2 | $2K | Sell |
121
-8,930
| -99% | -$148K | ﹤0.01% | 1163 |
|
|
2019
Q1 | $221K | Buy |
+9,051
| New | +$221K | 0.01% | 424 |
|
|
2018
Q4 | – | Sell |
-24,986
| Closed | -$791K | – | 1550 |
|
|
2018
Q3 | $791K | Sell |
24,986
-8,762
| -26% | -$277K | 0.05% | 266 |
|
|
2018
Q2 | $1.31M | Sell |
33,748
-7,162
| -18% | -$278K | 0.08% | 191 |
|
|
2018
Q1 | $1.13M | Sell |
40,910
-11,253
| -22% | -$311K | 0.08% | 206 |
|
|
2017
Q4 | $944K | Buy |
52,163
+14,120
| +37% | +$256K | 0.08% | 224 |
|
|
2017
Q3 | $614K | Buy |
+38,043
| New | +$614K | 0.06% | 290 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1596 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 1606 |
|
|
2016
Q2 | – | Sell |
-4,747
| Closed | -$90K | – | 1577 |
|
|
2016
Q1 | $90K | Buy |
+4,747
| New | +$90K | 0.01% | 730 |
|
|
2015
Q4 | – | Sell |
-100
| Closed | -$2K | – | 1468 |
|
|
2015
Q3 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 1339 |
|
|
2014
Q3 | – | Sell |
-400
| Closed | -$5K | – | 1841 |
|
|
2014
Q2 | $5K | Buy |
+400
| New | +$5K | ﹤0.01% | 1667 |
|